Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
ARS Pharmaceuticals, Inc. Reports Q1 2026 Financial Results
2026-05-15
SEC Filing 10-Q
(0001193125-26-225142)
Please check the link below for details.
Ticker mentioned:
SPRY
Source:
Original SEC Document β